335 related articles for article (PubMed ID: 30229456)
1. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
[TBL] [Abstract][Full Text] [Related]
2. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of cochlear implantation in patients with neurofibromatosis type 2.
North HJ; Mawman D; O'Driscoll M; Freeman SR; Rutherford SA; King AT; Hammerbeck-Ward C; Evans DG; Lloyd SK
Cochlear Implants Int; 2016 Jul; 17(4):172-177. PubMed ID: 27691934
[TBL] [Abstract][Full Text] [Related]
4. Cochlear implantation after radiosurgery for vestibular schwannoma.
Patel NS; Carlson ML; Link MJ; Neff BA; Van Gompel JJ; Driscoll CLW
J Neurosurg; 2021 Jul; 135(1):126-135. PubMed ID: 34250789
[TBL] [Abstract][Full Text] [Related]
5. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
[TBL] [Abstract][Full Text] [Related]
6. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
[TBL] [Abstract][Full Text] [Related]
7. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous cochlear implantation and translabyrinthine removal of vestibular schwannoma in an only hearing ear: report of two cases (neurofibromatosis type 2 and unilateral vestibular schwannoma).
Arístegui M; Denia A
Otol Neurotol; 2005 Mar; 26(2):205-10. PubMed ID: 15793406
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Cochlear Implantation in Neurofibromatosis Type 2 Related Hearing Loss.
Sobczak G; Marchant W; Misurelli S; Pyle GM; Gubbels S; Roche J
Ann Otol Rhinol Laryngol; 2023 Mar; 132(3):284-293. PubMed ID: 35450430
[TBL] [Abstract][Full Text] [Related]
10. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
11. Ipsilateral cochlear implantation after cochlear nerve preserving vestibular schwannoma surgery in patients with neurofibromatosis type 2.
Lloyd SK; Glynn FJ; Rutherford SA; King AT; Mawman DJ; O'Driscoll MP; Evans DG; Ramsden RT; Freeman SR
Otol Neurotol; 2014 Jan; 35(1):43-51. PubMed ID: 24335931
[TBL] [Abstract][Full Text] [Related]
12. Management strategy of vestibular schwannoma in neurofibromatosis type 2.
Odat HA; Piccirillo E; Sequino G; Taibah A; Sanna M
Otol Neurotol; 2011 Sep; 32(7):1163-70. PubMed ID: 21817944
[TBL] [Abstract][Full Text] [Related]
13. Cochlear implantation and auditory brainstem implantation in neurofibromatosis type 2.
Peng KA; Lorenz MB; Otto SR; Brackmann DE; Wilkinson EP
Laryngoscope; 2018 Sep; 128(9):2163-2169. PubMed ID: 29573425
[TBL] [Abstract][Full Text] [Related]
14. Cochlear implantation in patients with bilateral Ménière's syndrome.
Lustig LR; Yeagle J; Niparko JK; Minor LB
Otol Neurotol; 2003 May; 24(3):397-403. PubMed ID: 12806291
[TBL] [Abstract][Full Text] [Related]
15. Auditory brainstem implants in NF2 patients: results and review of the literature.
Sanna M; Di Lella F; Guida M; Merkus P
Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
[TBL] [Abstract][Full Text] [Related]
16. Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants.
Roehm PC; Mallen-St Clair J; Jethanamest D; Golfinos JG; Shapiro W; Waltzman S; Roland JT
J Neurosurg; 2011 Oct; 115(4):827-34. PubMed ID: 21761973
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous Translabyrinthine Tumor Removal and Cochlear Implantation in Vestibular Schwannoma Patients.
Kim JW; Han JH; Kim JW; Moon IS
Yonsei Med J; 2016 Nov; 57(6):1535-9. PubMed ID: 27593888
[TBL] [Abstract][Full Text] [Related]
18. Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2.
Lassaletta L; Aristegui M; Medina M; Aranguez G; Pérez-Mora RM; Falcioni M; Gavilán J; Piazza P; Sanna M
Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):27-35. PubMed ID: 25537817
[TBL] [Abstract][Full Text] [Related]
19. NF2-Related Intravestibular Schwannomas: Long-Term Outcomes of Cochlear Implantation.
Jia H; Nguyen Y; Hochet B; Smail M; Mosnier I; Wu H; Sterkers O; Kalamarides M; Bernardeschi D
Otol Neurotol; 2020 Jan; 41(1):94-99. PubMed ID: 31634276
[TBL] [Abstract][Full Text] [Related]
20. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
Harris F; Tysome JR; Donnelly N; Durie-Gair J; Crundwell G; Tam YC; Knight RD; Vanat ZH; Folland N; Axon P
Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
